Prevalence of Vancomycin-Resistant Enterococcus in a Teaching Hospital in Kashan, Iran

S. Sattar, D. Kheirkhah, A. Sharif, M. Azadchehr, Sareh Bagheri-Josheghani, M. Sharif
{"title":"Prevalence of Vancomycin-Resistant Enterococcus in a Teaching Hospital in Kashan, Iran","authors":"S. Sattar, D. Kheirkhah, A. Sharif, M. Azadchehr, Sareh Bagheri-Josheghani, M. Sharif","doi":"10.34172/ijep.2022.5522","DOIUrl":null,"url":null,"abstract":"Background: Enterococci bacteria are part of the intestinal microbial flora of humans and animals. However, the widespread use of antibiotics causes antibiotic resistance among these bacteria, making it necessary to identify effective antimicrobial agents against them. Objectives: This study aimed to investigate the phenotypic prevalence of vancomycin-resistant enterococci (VRE) in the clinical samples of patients admitted to Beheshti hospital in Kashan. Materials and Methods: This cross-sectional descriptive study was performed on 110 enterococci isolated from the clinical samples of hospitalized patients during 2017-2018. Vancomycin-resistant cases were identified and recorded after recording clinical and demographic information. Finally, the groups were statistically compared using chi-square and Fisher’s exact tests. Results: The present study findings demonstrated that the prevalence of VRE was 37.3%. There was a significant association between the prevalence of VRE and older age, diabetes, history of antibiotic use, and more extended hospital stays. Conversely, no significant relationship was found between VRE prevalence and gender, blood pressure, heart disease, year of sampling, and type of clinical sample. Conclusion: Overall, the incidence of vancomycin resistance in enterococci is increasing, which can be reduced by identifying effective antimicrobial agents and providing appropriate training to the medical staff and the general public.","PeriodicalId":31016,"journal":{"name":"International Journal of Enteric Pathogens","volume":"25 1","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2022-11-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"International Journal of Enteric Pathogens","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.34172/ijep.2022.5522","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

Background: Enterococci bacteria are part of the intestinal microbial flora of humans and animals. However, the widespread use of antibiotics causes antibiotic resistance among these bacteria, making it necessary to identify effective antimicrobial agents against them. Objectives: This study aimed to investigate the phenotypic prevalence of vancomycin-resistant enterococci (VRE) in the clinical samples of patients admitted to Beheshti hospital in Kashan. Materials and Methods: This cross-sectional descriptive study was performed on 110 enterococci isolated from the clinical samples of hospitalized patients during 2017-2018. Vancomycin-resistant cases were identified and recorded after recording clinical and demographic information. Finally, the groups were statistically compared using chi-square and Fisher’s exact tests. Results: The present study findings demonstrated that the prevalence of VRE was 37.3%. There was a significant association between the prevalence of VRE and older age, diabetes, history of antibiotic use, and more extended hospital stays. Conversely, no significant relationship was found between VRE prevalence and gender, blood pressure, heart disease, year of sampling, and type of clinical sample. Conclusion: Overall, the incidence of vancomycin resistance in enterococci is increasing, which can be reduced by identifying effective antimicrobial agents and providing appropriate training to the medical staff and the general public.
伊朗卡尚某教学医院耐万古霉素肠球菌的流行情况
背景:肠球菌是人类和动物肠道微生物菌群的一部分。然而,抗生素的广泛使用导致这些细菌产生抗生素耐药性,因此有必要确定针对它们的有效抗菌药物。目的:本研究旨在调查喀山Beheshti医院住院患者临床样本中万古霉素耐药肠球菌(VRE)的表型流行情况。材料与方法:本研究对2017-2018年住院患者临床样本中分离的110株肠球菌进行了横断面描述性研究。对万古霉素耐药病例进行临床和人口统计资料记录。最后,使用卡方检验和Fisher精确检验对两组进行统计学比较。结果:本研究结果显示,VRE的患病率为37.3%。VRE的流行与年龄、糖尿病、抗生素使用史和更长的住院时间之间存在显著关联。相反,VRE患病率与性别、血压、心脏病、采样年份和临床样本类型之间没有显著关系。结论:总体而言,肠球菌万古霉素耐药发生率呈上升趋势,可通过确定有效的抗菌药物并对医务人员和公众进行适当的培训来降低万古霉素耐药。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
自引率
0.00%
发文量
0
审稿时长
28 weeks
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信